172@29@16@60!~!172@29@0@53!~!|stocks|stock_market|corp_notices.php?autono=22182241!~!www|moneycontrol|com!~!|stocks|stock_market|corp_notices.php!~!is_mobile=false
Moneycontrol
SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements PharmaceuticalsAnnouncement - Dr Reddys Labs
Dr Reddys Labs
BSE: 500124NSE: DRREDDYISIN: INE089A01023

17th-Sep-2020 10:36Source: BSE

Dr Reddys Laboratories - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Dr. Reddy''s Laboratories announces settlement of
U.S. Revlimid® (lenalidomide) Capsules patent litigation with Celgene, a Bristol Myers
Squibb Company

Sections